Mycoplasma Pneumoniae IgM Hybrid Human Monoclonal Antibody

Ref. 3D-BM1412

Informations sur le produit

• Nom: Mycoplasma Pneumoniae IgM Hybrid Human Monoclonal Antibody

Description

Mycoplasma pneumoniae is a type of bacteria that infects the respiratory tract, causing infections such as pneumonia, bronchitis, and tracheobronchitis. Common symptoms of Mycoplasma pneumoniae infection include a persistent cough, sore throat, fatigue, fever, and sometimes chest pain. The onset of symptoms is usually gradual. The bacteria are typically spread through respiratory droplets produced when an infected person coughs or sneezes. Close contact with an infected person increases the risk of transmission. While most cases of Mycoplasma pneumoniae infections are mild, complications can occur, especially in individuals with weakened immune systems. Complications may include respiratory failure, neurological issues, and skin rashes.
Characterized disease state sera are critical components in the development and manufacture of diagnostic tests. However, sourcing of these sera is complicated, time-consuming, and sometimes suitable material is not available at all. Cymit Quimica provide monoclonal antibodies with lot-to-lot consistency, high specificity and that are produced under ISO 13485 and are reliable sourced.
Our Mycoplasma Pneumoniae IgM Hybrid Human Monoclonal Antibody is produced in mice genetically modified to express human IgM heavy chain constant region. They are then concentrated and spiked into an IgG depleted and delipidised human serum matrix which ensures that the final product is as close as possible to the natural disease state IgM positive human plasma. As part of the selection process for each antibody multiple clones were analysed by commercially available IgM assays and the clones with the most reactivity were selected for commercialization. Testing in both ELISA and bead-based applications shows the products behave in an almost identical manner as the natural source.

• Marque: Biosynth